What is ACHV stock price today?

ACHV (Achieve Life Sciences Inc) stock is trading at $5.02 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is ACHV stock going up or down today?

ACHV stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy ACHV stock now?

The decision to buy ACHV depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is ACHV a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for ACHV based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is ACHV stock overvalued or undervalued?

Use our DCF valuation calculator to determine if ACHV is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is ACHV's P/E ratio?

P/E ratio data for ACHV will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is ACHV's market cap?

ACHV (Achieve Life Sciences Inc) has a market capitalization of $0.53 billion, making it a small-cap stock.

What is ACHV's price to book ratio?

ACHV trades at a price-to-book (P/B) ratio of 47.30, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does ACHV pay dividends?

ACHV does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is ACHV's dividend yield?

ACHV does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is ACHV stock a good long-term investment?

ACHV's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is ACHV's revenue growth rate?

Revenue growth data for ACHV is available on our dashboard with detailed financial statement analysis.

Profitability metrics for ACHV are available on our dashboard with complete income statement analysis.

What are the risks of investing in ACHV?

Key risks for ACHV include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does ACHV compare to its competitors?

Compare ACHV to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize ACHV's performance and positioning.

What is ACHV's stock price target for 2026?

Our AI model provides price targets for ACHV based on fundamental analysis: Bull case $6.53 (+30%), Base case $5.77 (+15%), Bear case $4.52 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about ACHV?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for ACHV. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is ACHV's next earnings report?

ACHV reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

ACHV - Achieve Life Sciences Inc

NYSE * Healthcare * Biotechnology

$5.02

$-0.27 (-5.10%)

About Achieve Life Sciences Inc

Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms. It has license and supply agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.

Price Chart

Loading chart...

ACHV Key Statistics

Market Cap

$532.80M

P/B Ratio

47.30

EPS

$-1.07

Employees

How ACHV Compares to Peers

ACHV is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 5

Growth Rank

N/A

of 5

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
ACHV(This stock)	$532.80M	N/A	0%	0.0%	-
AMGNAmgen Inc	$186.52B	24.0	0%	0.2%	vs AMGN
GILDGilead Sciences	$160.39B	17.6	0%	0.3%	vs GILD
VRTXVertex Pharmaceuticals	$112.12B	26.2	0%	0.4%	vs VRTX
REGNRegeneron Pharmaceuticals	$66.84B	15.6	0%	0.3%	vs REGN
BIIBBiogen Inc	$29.00B	21.1	0%	0.1%	vs BIIB

Achieve Life Sciences Inc Company Information

Headquarters: 22722 29th Dr. SE, Bothell, WA, United States, 98021, undefined
Website: www.achievelifesciences.com
Sector: Healthcare
Industry: Biotechnology

Data Updated: June 5, 2026 at 1:34 PM EDT

Ready to invest in ACHV?

Commission-free trading available. Affiliate links.

ACHV Lician Score

5% confidence

4.0/10

Neutral

ACHV has a Lician Score of 4/10 (Average). Areas of concern: Growth.

value

5.0

growth

2.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates ACHVacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

ACHV Financial Snowflake

5-axis analysis across key investment dimensions

4.4/10

Neutral

5.0

Value

Valuation vs. sector peers

2.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for ACHV

Dashboard

Enter a ticker to analyze